In this webinar, Dr Kulasinghe shares insights from deep tissue profiling and discusses cutting-edge technological advances in tumour profiling to understand the spatial relationships of cells. Learn how profiling every cell within a tumour specimen provides a new lens through which to interpret therapy resistance in head and neck, skin and lung cancers.
Prof Wiesenfeld was appointed as Oral and Maxillofacial Surgeon with an interest in Oral Cancer at The Royal Melbourne Hospital (RMH) in 1983. He has held appointments at Peter MacCallum Cancer Centre as an Oral and Maxillofacial Surgeon and served as Head of the Head and Neck Tumour Stream at RMH for eight years. In 2015, he was appointed as Director of the Head and Neck Tumour Stream across the shared clinical services of Peter Mac and RMH. He is Past Chairman of the Australian and New Zealand Head and Neck Cancer Society Research Foundation and a Past President of ANZHNCS.
In 2018, Prof Wiesenfeld was appointed the VCCC Alliance Research & Education Lead – Head and Neck Cancer. In this role, he is working to map opportunities across the alliance to develop expert networks, deliver strategic educational programming, improve sharing of data for research, and implement multi-partner clinical trials to speed up the translation of new research into routine clinical practice.
Dr Arutha Kulasinghe is a Senior Research Fellow and leads the Clinical-oMx Lab at the University of Queensland. Dr Kulasinghe has pioneered spatial transcriptomics using digital spatial profiling approaches in the Asia-Pacific region, contributing to world-first studies for lung cancer, head and neck cancer, and COVID-19. His research aims to understand the underlying pathobiology by using an integrative multi-omics approach.
